Pharma Commerce editor takes a look back at 2023’s impressionable editorial content.
Related Posts
Understanding the Impact of the Veradigm Network on Value-Based Healthcare Delivery
As healthcare is moving toward the shared goal of improving patient care more economically, stakeholders across the spectrum are increasingly…
FDA Approves Padcev Plus Keytruda for Urothelial Cancer
The FDA previously granted the application for Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) with priority review and breakthrough designation for…
FDA to Evaluate Application for MDMA to Become First Approved Psychedelic Drug for PTSD
MAPS Public Benefit Corporation was previously granted Breakthrough Therapy Designation by the FDA for MDMA and is seeking a priority…